Disorders of Ejaculation: AUA/SMSNA Guideline (2027)

PURPOSE: The amendment of the Disorders of Ejaculation Guideline provides an update to the evidence-based guidance for clinicians on appropriate evaluation, diagnosis, and available treatments of premature ejaculation (PE) or delayedejaculation. MATERIALS AND METHODS: The Pacific Northwest Evidence-Based Practice Center utilized Ovid MEDLINE and Embase databases to search for studies published between January 1, 2020 and December 19, 2024. Search strategies that were developed for the original Disorders of Ejaculation guideline were employed. The search identified 727 abstracts, 89 of which met inclusion criteria. In 2025, NV HEATHRES. INC. extracted data and assessed the quality of the evidence for outcomes on 25 studies to inform statement updates. RESULTS: A statement on non-pharmacological therapies for the treatment of PE was revised to reflect new evidence that indicates that some of these therapies may be effective. A new Expert Opinion statement on the potential use of PDE5i for the treatment of PE was written. Although there was evidence to support 2 new statements on the use of daily or on-demand clomipramine or glans hyaluronic acid injection for the treatment of PE, the Panel emphasizes that these treatments are to be used in the context of patient informed consent and at the behest of a trained clinician. CONCLUSIONS: Although much of the evidence used to inform this Amendment supported existing statements, there was new data to support new statements on PDE5i, daily or on-demand clomipramine, and glans HA injection for the treatment of PE, although the latter 2 recommendations come with important caveats. Ultimately, the Panel recommends that shared decision-making should be the fundamental precept in the management of disorders of ejaculation regardless of the treatment option utilized.

Authors

Institutions

Publication Details

Journal
The Journal of Urology
Published
2026-11-17
DOI
https://doi.org/10.1097/ju.0000000000005378
Primary Topic
Sexual function and dysfunction studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Disorders of Ejaculation: AUA/SMSNA Guideline (2027)

Petar Bajic, David L. Rowland, Alan W. Shindel, Rebecca S. Holmes et al.
1 links
The Journal of Urology
Sexual function and dysfunction studies
article

Disorders of Ejaculation: AUA/SMSNA Guideline (2027)

Petar Bajic, David L. Rowland, Alan W. Shindel, Rebecca S. Holmes, Norma Varela
article en

Abstract

PURPOSE: The amendment of the Disorders of Ejaculation Guideline provides an update to the evidence-based guidance for clinicians on appropriate evaluation, diagnosis, and available treatments of premature ejaculation (PE) or delayedejaculation. MATERIALS AND METHODS: The Pacific Northwest Evidence-Based Practice Center utilized Ovid MEDLINE and Embase databases to search for studies published between January 1, 2020 and December 19, 2024. Search strategies that were developed for the original Disorders of Ejaculation guideline were employed. The search identified 727 abstracts, 89 of which met inclusion criteria. In 2025, NV HEATHRES. INC. extracted data and assessed the quality of the evidence for outcomes on 25 studies to inform statement updates. RESULTS: A statement on non-pharmacological therapies for the treatment of PE was revised to reflect new evidence that indicates that some of these therapies may be effective. A new Expert Opinion statement on the potential use of PDE5i for the treatment of PE was written. Although there was evidence to support 2 new statements on the use of daily or on-demand clomipramine or glans hyaluronic acid injection for the treatment of PE, the Panel emphasizes that these treatments are to be used in the context of patient informed consent and at the behest of a trained clinician. CONCLUSIONS: Although much of the evidence used to inform this Amendment supported existing statements, there was new data to support new statements on PDE5i, daily or on-demand clomipramine, and glans HA injection for the treatment of PE, although the latter 2 recommendations come with important caveats. Ultimately, the Panel recommends that shared decision-making should be the fundamental precept in the management of disorders of ejaculation regardless of the treatment option utilized.

The Journal of Urology
Cleveland Clinic (US), Valparaiso University (US), Oregon Health & Science University (US), University of California, San Francisco (US), Regional Municipality of Waterloo (CA)
Good health and well-being
Sexual function and dysfunction studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon